Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 3/2010

01-07-2010 | Special Feature

Current status of CAD utilizing digital mammography in Japan

Author: Nachiko Uchiyama

Published in: Breast Cancer | Issue 3/2010

Login to get access

Abstract

In this article, we describe the function of computer-aided detection (CAD), the history of CAD in mammography, its current status, the differences between CAD in analog mammography and digital mammography, detection performance, and appropriate directions for its use.
Literature
1.
Yamada T, Ishibashi T, Sai M, Ohnuki K, Uematsu T, Matsumoto M, et al. Questionnaires for screening digital mammography in Japan: Part 2. JJABCS. 2008;17(3):230–42.
2.
Fujita H, Hara T, Matsubara T, Fukuoka D. Computer-aided diagnosis (CAD) in the field of breast-cancer image diagnosis. Med Imaging Inf Sci. 2006;23(2):19–26.
3.
Fujita H. Computer-aided diagnosis in mammography. Med Imaging Inf Sci. 2004;21(1):39–41.
4.
Fujita H. Principle of computer-aided diagnosis system for mammography. JJABCS. 1996;5(2):135–47.
5.
Doi K. Present status and future potential of computer-aided diagnostic (CAD) systems in mammography. JJABCS. 1996;5(2):149–55.
6.
Fujita H. Short survey on current status of computer-aided diagnosis (CAD). Jpn J Radiol Technol. 2007;63(12):1389–95.
7.
Takeo H. Detection system of candidate of breast cancer on CR mammography images. Med Imaging Inf Sci. 2004;21(1):72–8.
8.
Hasegawa A. FUJIFILM CAD for mammography. Jpn J Radiol Technol. 2007;63(12):1418–23.
9.
Baker JA, Rosen EL, Lo JY, Gimenez EI, Walsh R, Soo MS. Computer-aided detection (CAD) in screening mammography: sensitivity of commercial CAD systems for detecting architectural distortion. AJR. 2003;181:1083–8.PubMed
10.
Tourassi GD, Floyd CE Jr. Performance evaluation of an information-theoretic CAD scheme for the detection of mammographic architectural distortion. Proc SPIE. 2004;5370:59–66.CrossRef
11.
12.
13.
14.
15.
Fenton JJ, Taplin SH, Carney PA, Abraham L, Sickels EA, D’Orsi C, et al. Influence of computer-aided detection on performance of screening mammography. NEJM. 2007;356:1399–409.CrossRefPubMed
16.
17.
18.
Kano A. Development of a computerized image processing system for the aid of diagnosis of breast cancer. Med Imaging Inf Sci. 2004;21(1):79–83.
19.
Freer TW, Ulissey MJ. Screening mammography with CAD: prospective study of 12,860 patients in a community breast center. Radiology. 2001;220:781–6.CrossRefPubMed
20.
Birdwell R, Bandodkar P, Ikeda D. Computer aided detection (CAD) with screening mammography in a university hospital setting. Radiology. 2005;236:451–7.CrossRefPubMed
21.
Morton MJ, Whaley DH, Brandt KR, Amrami KK. Screening mammograms: interpretation with computer-aided detection—prospective evaluation. Radiology. 2006;239:375–83.CrossRefPubMed
22.
Dean JC, Ilvento CC. Improved cancer detection using computer-aided detection with diagnostic and screening mammography: prospective study of 104 cancers. AJR. 2006;187:20–8.CrossRefPubMed
23.
Ko JM, Nicholas MJ, Mendel JB, Slanetz PJ. Prospective assessment of computer-aided detection in interpretation of screening mammography. AJR. 2006;187:1483–91.CrossRefPubMed
24.
Hall FM. Breast imaging and computer-aided detection. NEJM. 2007;356:1464–6 (Editorial).
25.
Nishikawa RM, Schmidt RA, Metz CE. Computer-aided screening mammography. NEJM. 2007;357:83–5 (Correspondence).
26.
Gilbert FJ, Astley SM, Gillan MGC, Agbaje OF, Wallis MG, James J, et al. Single reading with computer-aided detection for screening mammography. NEJM. 2008;359:1675–84.CrossRefPubMed
27.
Gilbert FJ, Astley SM, McGee MA, Gillan MGC, Boggis CRM, Griffiths PM, et al. Single reading with computer-aided detection and double reading of screening mammograms in the United Kingdom national breast screening program. Radiology. 2006;241:47–53.CrossRefPubMed
28.
Uchiyama N. Present topics of CAD in mammography. Med Imaging Inf Sci. 2008;25(2):26–8.
29.
Gur D, Sumkin JH, Rockette HE, Ganott M, Hakim C, Hardesty L, et al. Changes in breast cancer detection and mammography recall rates after the introduction of a computer-aided detection system. J Natl Cancer Inst. 2004;96:185–90.CrossRefPubMed
Metadata
Title
Current status of CAD utilizing digital mammography in Japan
Author
Nachiko Uchiyama
Publication date
01-07-2010
Publisher
Springer Japan
Published in
Breast Cancer / Issue 3/2010
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-010-0202-0

Other articles of this Issue 3/2010

Breast Cancer 3/2010 Go to the issue

Review Article

Comprehensive geriatric assessment in elderly breast cancer patients

Special Feature

Digital mammographic screening in Japan

Special Feature

Digital mammography in Japan

Original Article

Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer

Special Feature

Diagnostic digital mammography in Japan: issues to consider

Original Article

Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits